Celyad Oncology SA (CLYYF)
0.245
0.00 (0.00%)
USD |
OTCM |
Nov 26, 16:00
Celyad Oncology Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 26, 2024 | 1.091M |
| November 25, 2024 | 1.091M |
| November 22, 2024 | 1.091M |
| November 21, 2024 | 1.091M |
| November 20, 2024 | 1.091M |
| November 19, 2024 | 1.091M |
| November 18, 2024 | 1.091M |
| November 15, 2024 | 1.091M |
| November 14, 2024 | 1.091M |
| November 13, 2024 | 1.091M |
| November 12, 2024 | 1.091M |
| November 11, 2024 | 1.091M |
| November 08, 2024 | 1.091M |
| November 07, 2024 | 1.091M |
| November 06, 2024 | 1.091M |
| November 05, 2024 | 1.091M |
| November 04, 2024 | 1.091M |
| November 01, 2024 | 1.091M |
| October 31, 2024 | 1.091M |
| October 30, 2024 | 1.091M |
| October 29, 2024 | 1.091M |
| October 28, 2024 | 1.091M |
| October 25, 2024 | 1.091M |
| October 24, 2024 | 1.091M |
| October 23, 2024 | 1.091M |
| Date | Value |
|---|---|
| October 22, 2024 | 1.091M |
| October 21, 2024 | 1.091M |
| October 18, 2024 | 1.091M |
| October 17, 2024 | 1.091M |
| October 16, 2024 | 1.091M |
| October 15, 2024 | 1.091M |
| October 14, 2024 | 1.091M |
| October 11, 2024 | 1.091M |
| October 10, 2024 | 1.091M |
| October 09, 2024 | 1.091M |
| October 08, 2024 | 1.091M |
| October 07, 2024 | 1.091M |
| October 04, 2024 | 1.091M |
| October 03, 2024 | 1.091M |
| October 02, 2024 | 1.091M |
| October 01, 2024 | 1.091M |
| September 30, 2024 | 1.091M |
| September 27, 2024 | 1.091M |
| September 26, 2024 | 1.091M |
| September 25, 2024 | 1.091M |
| September 24, 2024 | 1.091M |
| September 23, 2024 | 1.091M |
| September 20, 2024 | 1.091M |
| September 19, 2024 | 1.091M |
| September 18, 2024 | 1.091M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.198M
Minimum
May 26 2023
97.99M
Maximum
Dec 08 2021
31.56M
Average
7.697M
Median
Jul 21 2023
Enterprise Value Benchmarks
| Galapagos NV | -1.956B |
| UCB SA | 38.50B |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 246.90M |
| MDxHealth SA | 98.11M |